F O R C L I N I C A L T R I A L S
Social Intelligence
Michael Durwin
Dir. of Social Intelligence & Communities,
ICON, North America
SocialIntel
Why
Social
Media?
97% US
58%
World
S O C I A L M E D I A R E A C H
3 1 9 . 6 M I L L I O N
4 . 5 8 B I L L I O N
H E A L T H I N F O R M A T I O N S H A R I N G
87%
91%
D e c i s i o n s
I n f o r m e d
B y O n l i n e C o m m u n i t i e s
70%
C a r e g i v e r S e e k i n g
S u p p o r t & I n f o r m a t i o n
52%
C a r e g i v e r
P a r t i c i p a t i o n
I n H e a l t h - R e l a t e d
O n l i n e A c t i v i t y
Tal
k
i
n
g
About
Health
Negative
|
Positive
Social
Listening
WhatAbout
Privacy?
Public
Only!
Content
Patients
Want
ToBeHeard!
18
SOCIAL
INTELLIGENCE
19
SOCIAL
INTELLIGENCE
“The practical application of
digital conversations to answer
questions and solve challenges
using qualitative data in a
quantitative mode.
”
20
SOCIAL
INTELLIGENCE
“The practical application of
digital conversations to answer
questions and solve challenges
using qualitative data in a
quantitative mode.
”
21
SOCIAL
INTELLIGENCE
“The practical application of
digital conversations to answer
questions and solve challenges
using qualitative data in a
quantitative mode.
”
22
2,982,232,320
SinceJanuary2020
23
33,152,379
APRIL
24
5
PRINCIPLES
1. Public Data Only
2. Avoid bias through
diversity
3. Use audience language,
not industry buzzwords
4. Layer your tools & data
sources
5. Be flexible
25
DATA
DIVERSITY
PATIENTLANGUAGE
ACUTEPHARYNGITIS
RHINITIS
MYALGIA
DERMATITIS
ECCHYMOSIS
SORETHROAT
STUFFYNOSE
SOREMUSCLES
RASH
BRUISE
TOOLS
FLEXIBLE
Participation
LikelyTrial
SEGMENTS
Patient
Engaged
Health
Blockers
Participation
Considerations
Socio-Economic
Symptoms
Geography
Habits
Media
Treatments Trust
Symptoms
Habits
Recruitment
STUDY
AdverseEvent
MONITORING
Outbreak
PREDICTION
Trends
PATIENT
iconplc.com
© 2021 ICON. All rights reserved. Internal use only.
Thank you.
Social Intelligence & Communities Team
Michael.Durwin@iconplc.com
www.ICONPLC.com
CONTACT

Social Intelligence for Clinical Trials.pptx